Skip to main content
Top
Published in: CEN Case Reports 2/2014

01-11-2014 | Case Report

Tophaceous pseudogout in a patient undergoing peritoneal dialysis

Authors: Rika Jimbo, Hidekazu Iida, Yoshitaka Ishibashi

Published in: CEN Case Reports | Issue 2/2014

Login to get access

Abstract

Calcium pyrophosphate dihydrate deposition disease (pseudogout) is a crystal arthritis characterized by pyrophosphate dihydrate crystal deposition in the articular cartilage or synovium. In chronic kidney disease patients, the major causes of crystal arthritis are calcium oxalate crystals and basic calcium phosphate crystals. However, pseudogout is apparently infrequent among such patients. This report describes a rare case of tophaceous pseudogout (tumoral form of pseudogout) involving the hip joint in a peritoneal dialysis patient, as revealed by CT scan and synovial fluid aspiration. Fluid aspiration and oral NSAIDs improved the clinical symptoms. This report is the first to describe tophaceous pseudogout in a peritoneal dialysis patient, which suggests that pseudogout should be suspected in dialysis patients with unexplained arthritis.
Literature
1.
go back to reference Yildiz N, Ardic F, Ercidogan O, et al. Acute pseudogout arthritis in a patient with chronic renal failure: a case report. Clin Nephrol. 2008;70:424–6.PubMedCrossRef Yildiz N, Ardic F, Ercidogan O, et al. Acute pseudogout arthritis in a patient with chronic renal failure: a case report. Clin Nephrol. 2008;70:424–6.PubMedCrossRef
2.
go back to reference Lee SI, Yoo WH, Jang YB, et al. Pseudogout: a cause of acute arthritis of the right ankle in a uremic patient. Clin Nephrol. 2006;66:310–1.PubMedCrossRef Lee SI, Yoo WH, Jang YB, et al. Pseudogout: a cause of acute arthritis of the right ankle in a uremic patient. Clin Nephrol. 2006;66:310–1.PubMedCrossRef
3.
go back to reference Aoyagi R, Maruyama S, Gejo F, et al. A case of pseudogout (PPD storage disease) which associated with long-term dialysis patient. Kidn Metab Bone Dis. 1991;4(545–4):550. Aoyagi R, Maruyama S, Gejo F, et al. A case of pseudogout (PPD storage disease) which associated with long-term dialysis patient. Kidn Metab Bone Dis. 1991;4(545–4):550.
4.
go back to reference Kamijo Y, Iida H, Saito K, Furutera R, Ishibashi Y. Normal peritoneum after 9-years of peritoneal dialysis with biocompatible dialysate: a Case report. Perit Dial Int (In press). Kamijo Y, Iida H, Saito K, Furutera R, Ishibashi Y. Normal peritoneum after 9-years of peritoneal dialysis with biocompatible dialysate: a Case report. Perit Dial Int (In press).
5.
go back to reference Tsukamoto M, Ishibashi Y, Takazawa Y, Komemushi Y, Kume H. Normal peritoneal histology after 10 years of peritoneal dialysis in a contemporary Japanese patient. Perit Dial Int. 2013;33:463–4.PubMedCentralPubMedCrossRef Tsukamoto M, Ishibashi Y, Takazawa Y, Komemushi Y, Kume H. Normal peritoneal histology after 10 years of peritoneal dialysis in a contemporary Japanese patient. Perit Dial Int. 2013;33:463–4.PubMedCentralPubMedCrossRef
6.
go back to reference Lawrence MR, McCarty DJ. Calcium pyrophosphate deposition disease, Pseudogout, and articular chondrocalcinosis. In: Arthritis and allied conditions: a textbook of rheumatology 15th edn, Lippincott: Williams & Wilkins; 2004. pp. 2373–2397. Lawrence MR, McCarty DJ. Calcium pyrophosphate deposition disease, Pseudogout, and articular chondrocalcinosis. In: Arthritis and allied conditions: a textbook of rheumatology 15th edn, Lippincott: Williams & Wilkins; 2004. pp. 2373–2397.
7.
go back to reference Zhang W, Doherty M, Bardin T, et al. EULAR recommendations for calcium pyrophosphate crystal associated arthritis. Part I: terminology and diagnosis. Ann Rheum Dis. 2011;70:563–70.PubMedCrossRef Zhang W, Doherty M, Bardin T, et al. EULAR recommendations for calcium pyrophosphate crystal associated arthritis. Part I: terminology and diagnosis. Ann Rheum Dis. 2011;70:563–70.PubMedCrossRef
8.
go back to reference Ishida T, Dorfman HD, Bullough PG. Tophaceous pseudogout (tumoral calcium pyrophosphate dihydrate crystal deposition disease). Hum Pathol. 1995;26:587–93.PubMedCrossRef Ishida T, Dorfman HD, Bullough PG. Tophaceous pseudogout (tumoral calcium pyrophosphate dihydrate crystal deposition disease). Hum Pathol. 1995;26:587–93.PubMedCrossRef
9.
go back to reference Braunstein EM, Menerey K, Martel W, Swartz R, Fox IH. Radiologic features of a pyrophosphate-like arthropathy associated with long-term dialysis. Skel Radiol. 1987;16:437–41.CrossRef Braunstein EM, Menerey K, Martel W, Swartz R, Fox IH. Radiologic features of a pyrophosphate-like arthropathy associated with long-term dialysis. Skel Radiol. 1987;16:437–41.CrossRef
10.
go back to reference Chalmers A, Reynolds WJ, Oreopoulos DG, Meema HE, Meindok H, deVeber GA. The arthropathy of maintenance intermittent peritoneal dialysis. Can Med Assoc J. 1980;123:635–8.PubMedCentralPubMed Chalmers A, Reynolds WJ, Oreopoulos DG, Meema HE, Meindok H, deVeber GA. The arthropathy of maintenance intermittent peritoneal dialysis. Can Med Assoc J. 1980;123:635–8.PubMedCentralPubMed
11.
go back to reference Announ N, Palmer G, Guerne PA, et al. Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure. Jt Bone Spine. 2009;76:424–6.CrossRef Announ N, Palmer G, Guerne PA, et al. Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure. Jt Bone Spine. 2009;76:424–6.CrossRef
12.
go back to reference Ellman MH, Brown NL, Katzenberg CA. Acute pseudogout in chronic renal failure. Arch Intern Med. 1979;139:795–6.PubMedCrossRef Ellman MH, Brown NL, Katzenberg CA. Acute pseudogout in chronic renal failure. Arch Intern Med. 1979;139:795–6.PubMedCrossRef
13.
go back to reference Zhang W, Doherty M, Pascual E, et al. EULAR recommendations for calcium pyrophosphate deposition. Part II: management. Ann Rheum Dis. 2011;70:571–5.PubMedCrossRef Zhang W, Doherty M, Pascual E, et al. EULAR recommendations for calcium pyrophosphate deposition. Part II: management. Ann Rheum Dis. 2011;70:571–5.PubMedCrossRef
Metadata
Title
Tophaceous pseudogout in a patient undergoing peritoneal dialysis
Authors
Rika Jimbo
Hidekazu Iida
Yoshitaka Ishibashi
Publication date
01-11-2014
Publisher
Springer Japan
Published in
CEN Case Reports / Issue 2/2014
Electronic ISSN: 2192-4449
DOI
https://doi.org/10.1007/s13730-013-0107-9

Other articles of this Issue 2/2014

CEN Case Reports 2/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine